Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-24-027145
Filing Date
2024-07-12
Accepted
2024-07-12 17:30:56
Documents
41

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 4053765
2 ex1-1.htm EX-1.1 294803
3 ex3-6.htm EX-3.6 14354
4 ex5-1.htm EX-5.1 19881
5 ex10-35.htm EX-10.35 243962
6 ex10-36.htm EX-10.36 240289
7 ex10-37.htm EX-10.37 230291
8 ex10-38.htm EX-10.38 261967
9 ex10-39.htm EX-10.39 80663
10 ex10-40.htm EX-10.40 449972
11 ex23-1.htm EX-23.1 4045
12 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 17502
13 forms-1a_001.jpg GRAPHIC 50688
14 image_004.jpg GRAPHIC 5280
15 forms-1a_026.jpg GRAPHIC 16829
16 img_001.jpg GRAPHIC 6974
17 form1-a_026.jpg GRAPHIC 6518
18 forms1-a_005.jpg GRAPHIC 12847
19 forms1-a_006.jpg GRAPHIC 31718
20 forms-1a_007.jpg GRAPHIC 28376
21 forms-1a_008.jpg GRAPHIC 21616
22 forms-1a_009.jpg GRAPHIC 34176
23 form1-a_027.jpg GRAPHIC 16169
24 forms-1a_012.jpg GRAPHIC 44539
25 forms-1a_013.jpg GRAPHIC 29198
26 forms-1a_014.jpg GRAPHIC 19502
27 forms-1a_016.jpg GRAPHIC 72845
28 forms-1a_017.jpg GRAPHIC 79629
29 forms-1a_18.jpg GRAPHIC 71617
30 forms1-a_025.jpg GRAPHIC 71110
31 form1-a_028.jpg GRAPHIC 1631
32 forms-1a_019.jpg GRAPHIC 1591
33 forms-1a_020.jpg GRAPHIC 4341
34 forms-1a_021.jpg GRAPHIC 1756
35 forms-1a_022.jpg GRAPHIC 2376
36 forms-1a_023.jpg GRAPHIC 2298
37 forms1-a_024.jpg GRAPHIC 1604
38 aud_001.jpg GRAPHIC 5266
39 aud_002.jpg GRAPHIC 2254
40 forms-1a_029.jpg GRAPHIC 7125
41 ex5-1_001.jpg GRAPHIC 42594
  Complete submission text file 0001493152-24-027145.txt   6869628
Mailing Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477
Business Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 (561) 406-6154
JUPITER NEUROSCIENCES, INC. (Filer) CIK: 0001679628 (see all company filings)

EIN.: 474828381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-260183 | Film No.: 241115333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)